Passage Bio, Inc. (NASDAQ:PASG – Get Free Report)’s share price traded down 6.5% on Monday . Wall Street Zen upgraded Passage Bio from a “strong sell” rating to a “sell” rating in a research report on Sunday, May 3rd. TD Cowen lowered Passage Bio from a “buy” rating to a “hold” rating in a research report on Tuesday, April 21st. Lucid Cap Mkts lowered Passage Bio from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 20th. Featured ArticlesReceive News & Ratings for Passage Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Passage Bio and related companies with MarketBeat.com's FREE daily email newsletter.